ADAR and hepatocellular carcinoma: Furthermore, Prickle-1 was capable of lowering Dsh in vitro and negatively regulated Wnt/β-catenin pathway by promoting Dsh degradation through ubiquitination in liver cancer (Prickle-1 was also found to be underexpressed in human hepatocellular carcinoma) [86].